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The initiating etiologic factor in Crohn’s disease (CD) remains unclear. SAMP1/YitFc (SAMP) 
mice develop chronic ileitis similar to human CD. We used bone marrow chimeras to deter-
mine if SAMP ileitis results from a primary immunological defect or from dysregulated 
mucosal immunity secondary to intrinsic, nonhematopoietic (e.g., epithelial) dysfunction. 
SAMP mice receiving wild-type (AKR) BM developed severe ileitis, whereas SAMP BM did 
not confer ileitis to WT recipients. WT lymphocytes from reconstituted SAMP mice resem-
bled native SAMP populations in regard to surface phenotype and cytokine production. Ilea 
from native SAMP mice and SAMP recipients of wild-type BM displayed decreased epithe-
lial barrier resistance ex vivo and increased epithelial permeability in vivo compared to 
native WT mice and AKR recipients of SAMP BM. This permeability defect preceded the 
development of ileal infl  ammation, was present in the absence of commensal bacteria, and 
was accompanied by altered ileal mRNA expression of the tight junction proteins claudin-2 
and occludin. Our results provide evidence that the primary defect conferring ileitis in 
SAMP mice originates from a nonhematopoietic source. Generation of pathogenic lympho-
cytes is a consequence of this defect and does not refl  ect intrinsic proinfl  ammatory leuko-
cyte properties. Decreased barrier function suggests that defects in the epithelium may 
represent the primary source of SAMP ileitis susceptibility.
Many considerable advances have recently been 
made in the fi  eld of Crohn’s disease (CD) re-
search, enabling both a better understanding 
of the mucosal immune system (1) and the 
advent of more eff  ective treatment modalities 
(2). However, the primary defect in genetically 
susceptible individuals that initiates the cascade 
of events leading to the development of disease 
remains largely unknown (3, 4). One of the 
key unresolved issues regarding this susceptibil-
ity trait, underscored by the fact that recently 
discovered susceptibility genes are expressed 
and possess independent functions in both he-
matopoietic cells and intestinal epithelial cells 
(5, 6), concerns the cells or tissue in which this 
precipitating factor originates.
Many lines of evidence suggest that a pri-
mary immunologic defect may be responsible 
for the development of CD (1). Aberrant lam-
ina propria mononuclear cell overexpression of 
T helper (Th)1 polarizing cytokines, such as 
IL-12 and IFNγ, has long been postulated as 
a potential causal factor of CD (7, 8). In mu-
rine adoptive transfer models, CD45RBhi or 
CD25− CD4+ T cell populations expressing 
these cytokines are suffi   cient to induce colitis 
with pathologic features resembling CD colitis 
(9, 10). Primary defects in the function of regu-
latory T cells, which can block colitis in animal 
models through TGFβ- and IL-10–dependant 
mechanisms (11), may give rise to intestinal 
infl   ammation by allowing excessive eff  ector 
responses to nonpathogenic fl  oral or food an-
tigens (12, 13). Increased serum autoreactiv-
ity in CD patients and the proinfl  ammatory 
  eff  ect of B cells in models of ileitis suggest that 
B lymphocyte specifi  city may be involved in 
  initiating the disease (14, 15), whereas the cu-
rative eff  ect of enhancing myeloid cell   function 
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in a cohort of CD patients (16) suggests that defects in mye-
loid cells may also play a critical role. Most convincingly, case 
reports have demonstrated complete remission in several CD 
patients after irradiation and allogeneic BM transplantation 
(17), suggesting a primary defect in immune cell function in 
these individuals.
Conversely, there are several lines of evidence suggesting 
that intestinal epithelial cells confer the primary susceptibility 
to CD. Paneth cell-derived NOD2 from normal individuals 
may play a critical role in the ability of epithelial cells to expel 
luminal bacteria, whereas CD-variant NOD2 lacks this func-
tion (6). Epithelial toll-like receptor expression is altered in 
CD patients (18), suggesting that the inability of the epithe-
lium to respond properly to common bacterial motifs might 
lead to disease initiation. Epithelial cytokine and chemokine 
expression is also increased in the context of CD (19, 20), 
possibly enabling the initial recruitment of infl  ammatory cells 
to lesion sites. Importantly, alterations in epithelial barrier 
function have been proposed to be a primary etiologic factor 
leading to CD, as intestinal permeability is dramatically in-
creased in CD patients relative to normal controls or ulcer-
ative colitis patients (3, 21). In fact, fi  rst degree relatives of 
CD patients who are at increased risk for developing the dis-
ease often have increased intestinal permeability relative to 
the general population (22, 23). Furthermore, increased epi-
thelial permeability often precedes and predicts relapse after 
remission for CD patients (24). Collectively, these fi  ndings 
suggest that dysregulated barrier function may be a prerequi-
site for the onset of intestinal infl  ammation such as that 
observed in CD (21).
Epithelial permeability is primarily controlled at the level 
of tight junctions (TJs). The density of TJ strands determines 
tissue-specifi  c size restrictions on passage through tight junc-
tional pores (25), with estimates suggesting that particles big-
ger than 2,000 D are typically excluded by intestinal epithelial 
TJs (26). The two major structural constituents of TJs are 
heterohexamers of claudins (isoforms 1–5), which form the 
actual pore, and the adjacent occludin molecules, both of 
which form homotypic interactions with counterparts on 
neighboring cells (27). Interactions between distinct claudin 
isoforms possess diff  erent affi   nities such that regulation of iso-
form-specifi  c expression patterns may provide one method of 
permeability regulation (28, 29). Only one isoform of occlu-
din is known, and its regulation occurs primarily through re-
localization of the protein by dephosphorylation (30). The 
large protein zonula occludens (ZO)-1 serves as a scaff  olding 
protein, linking claudins and occludins with the actinomyo-
sin ring of the epithelial cell. Many cellular signals aimed at 
altering permeability aff  ect the expression or junctional local-
ization of ZO-1 (31).
The SAMP1/YitFc (SAMP) murine model of chronic 
intestinal infl  ammation provides an excellent system in which 
to study the contributions made by specifi  c tissues and cell 
types to the development of CD, partly because it is one of 
the few models in which infl  ammation is most severe in the 
terminal ileum, the hallmark location of CD lesions (32, 33). 
Additionally, because this mouse strain was derived from 
brother-sister breeding of WT AKR mice (34), the pheno-
type occurs spontaneously as in the human condition, with-
out chemical, genetic, or immunologic manipulation. The 
infl  ammatory lesions develop by 10 wk of age (35) and mostly 
consist of Th1-type immune responses (36), although Th2-
polarizing cytokines also contribute to disease pathogenesis 
(37). Mesenteric lymph node (MLN) CD4+ T cells, capable 
of adoptively transferring the ileitis phenotype to SCID mice, 
and aberrantly expanded MLN and lamina propria B cell 
populations help drive the SAMP ileal infl  ammatory response 
(36, 38), and the severity of disease can be decreased by either 
antibiotics or anti-TNF antibodies (39, 40). Genetic outcross 
studies and linkage analysis have identifi  ed loci on several 
SAMP chromosomes with polymorphic markers that segre-
gate with the ileitis phenotype, including polymorphisms in 
the promoter region of the peroxisome proliferator-activated 
receptor-γ (Pparγ) gene that aff  ect expression in an epithelial 
cell–specifi  c fashion (41,42).
In the present study, we investigated whether the primary 
etiologic factor responsible for SAMP ileitis originates from 
immune cells or a nonhematopoietic source, such as the 
  intestinal epithelium. Construction of chimeric mice was 
achieved using BM transplantation in which AKR and SAMP 
mice were reconstituted with SAMP and AKR BM, respec-
tively, and assayed for the severity of gut infl  ammation. We 
next examined the eff  ect of exchanging hematopoietic cell 
compartments on the size of lymphocyte subsets and T cell 
cytokine production within recipient mice. Epithelial barrier 
function was then evaluated in both native SAMP and AKR 
mice as well as in bone marrow transplant (BMT) recipients. 
We then performed a time-course study, comparing the on-
set of the permeability defect in SAMP ileum versus the de-
velopment of ileal infl  ammation and neutrophil infi  ltration in 
both conventionally housed and germ-free (GF) SAMP mice. 
Finally, we examined the expression of TJ proteins in young 
SAMP versus AKR ileum, before the onset of infl  ammation, 
to determine whether diff  erential regulation of these proteins 
may lead to the permeability defect. Collectively, our data 
demonstrate that a nonhematopoietic tissue, likely the intes-
tinal epithelium, contains the primary ileitis susceptibility 
factor in SAMP mice, and this factor, which may involve 
  aberrant TJ formation leading to increased paracellular per-
meability through the epithelial barrier, is capable of edu-
cating normal WT leukocytes to become pathogenic and 
promote the development of CD-like ileitis.
RESULTS
BMT between SAMP and AKR mice results 
in full leukocyte reconstitution
To test relative contributions of the epithelium and leuko-
cytes to the primary ileitis susceptibility in SAMP mice, we 
generated BM chimeras by reconstituting irradiated SAMP 
mice with WT AKR BM (AKR BM → SAMP) and irra-
diated AKR mice with SAMP BM (SAMP BM → AKR). 
We tested the amount of hematopoietic cell reconstitution JEM VOL. 203, March 20, 2006  543
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by transplanting female recipients with male BM cells and 
assaying for the amount of Y chromosome DNA within leu-
kocyte compartments 6 wk after irradiation and transplanta-
tion using quantitative real-time PCR. By comparing with a 
standard curve of known ratios of male to female DNA, we 
determined that reconstitution was ≥94% for AKR BM → 
SAMP and SAMP BM → AKR splenocytes. The percentage 
of reconstitution was >80% in all tissues assayed, with a trend 
toward slightly higher reconstitution in SAMP BM → AKR 
mice versus AKR BM → SAMP mice.
Ileitis phenotype tracks with SAMP host/epithelium, 
not SAMP BM
We next assessed infl  ammation severity in reciprocal BMT 
mice 6 wk after transplant using an established histologic scor-
ing system (43). AKR BM → SAMP mice exhibited a trend 
toward slightly higher levels of overall infl  ammation (total 
infl  ammatory index, 14 ± 1, mean ± SEM) compared with 
native SAMP mice (11 ± 1) (Fig. 1 A). The transplantation 
procedure itself may increase the severity of SAMP ileitis, 
as SAMP BM → SAMP possessed signifi  cantly higher ileal 
infl  ammatory scores (18 ± 0) compared with native SAMP 
mice. However, SAMP BM → SAMP ileitis was not signifi  -
cantly more severe than AKR BM → SAMP ileitis. Further-
more, the infl  ammatory scores in AKR BM → SAMP ilea 
for all three individual histologic indices, including epithelial 
architectural destruction as well as active and chronic infl  am-
mation, were comparable to scores for native SAMP mice. 
In contrast, SAMP BM → AKR mice developed only mild, 
if any, infl  ammation (1.4 ± 0.7), comparable to levels seen 
in irradiated AKR mice reconstituted with AKR BM (1.2 ± 
1.2), suggesting that the primary susceptibility leading to ileitis 
in SAMP mice originates from a nonhematopoietic source. 
Ileal infl  ammatory scores from either AKR BM → SAMP or 
SAMP BM → AKR mice at 12 wk after transplant followed 
the same pattern, with AKR BM → SAMP mice exhibiting 
severe ileitis and SAMP BM → AKR mice developing only 
mild infl  ammation (unpublished data). Scores at 12 wk after 
transplant were not signifi  cantly diff  erent from the respective 
scores in the same group of mice at 6 wk after transplant.
The ileitis in AKR BM → SAMP mice was histopatholog-
ically similar to that observed in native SAMP mice (Fig. 1 B). 
Both AKR BM → SAMP and native SAMP ileum displayed 
thickening of the muscularis layer and dense infl  ammatory 
infi  ltrates composed of both acute and chronic infl  ammatory 
cells throughout the villi and within the submucosa. Addition-
ally, several epithelial abnormalities observed in SAMP mice 
were also noted in AKR BM → SAMP mice, including vil-
lous blunting, crypt hypertrophy and elongation, and abnor-
mal hypertrophy and hyperplasia of Paneth and goblet cells.
Figure 1.  Ileitis is dependent on host/nonhematopoietic compart-
ment and not donor BM. (A) Disease severity was assessed in SAMP 
(n = 7), AKR (n = 5), SAMP BM → SAMP (n = 5), AKR BM → SAMP 
(n = 10), AKR BM → AKR (n = 3), and SAMP BM → AKR (n = 10) mice. 
*Signifi  cant difference in infl  ammatory score between SAMP BM → AKR 
and AKR BM → SAMP mice. (B) Histologic evaluation of ileal sections 
from SAMP and AKR BM → SAMP mice shows large infl  ammatory infi  l-
trates and epithelial abnormalities including crypt hypertrophy and elon-
gation (arrowheads), and Paneth cell hyperplasia (arrows). Sections from 
AKR and SAMP BM → AKR mice display normal architecture.544  PRIMARY NONHEMATOPOIETIC SOURCE FOR CHRONIC ILEITIS | Olson et al. 
Size and pathogenicity of MLN lymphocyte subsets 
determined by infl  ammatory status of host
Given the extensive characterization of surface marker and 
cytokine expression diff  erences between SAMP and AKR 
MLN populations in previous studies (36, 38) and the ability 
of SAMP MLN lymphocytes to transfer ileitis to SCID mice, 
we next examined lymphocyte populations in AKR BM → 
SAMP and SAMP BM → AKR MLN. In 6–12-wk-old mice 
used as BM donors, SAMP MLN had increased percentages 
of IgA+ B cells (8.2 ± 0.8% versus 2.6 ± 0.3%, mean ± SEM) 
and CD4+ T cells expressing the activation marker CD69 
(29 ± 2% versus 13 ± 1%) relative to AKR MLN (Fig. 2, A 
and B). Interestingly, MLN from AKR BM → SAMP mice 
contained elevated percentages of CD4+ T cells expressing 
CD69 (31 ± 2%) and IgA+ B cells (12 ± 1%) similar to that 
seen in native SAMP MLN, even though the vast majority of 
MLN lymphocytes in AKR BM → SAMP mice are derived 
from AKR BM. Likewise, MLN from SAMP BM → AKR 
contained low percentages of CD4+ T cells expressing CD69 
and IgA+ B cells, similar to the size of these populations in 
native AKR mice, even though MLN lymphocytes in SAMP 
BM → AKR mice are derived from SAMP BM. Furthermore, 
most of the other lymphocyte populations that were increased 
in SAMP relative to AKR MLN were also increased in AKR 
BM → SAMP MLN relative to SAMP BM → AKR MLN, 
including the percentage of CD4+ T cells that are β7 integ-
rinhi (15 ± 1% versus 8 ± 2%), αE integrin+ (11 ± 1% versus 
5.8 ± 0.7%), CD25+ (15 ± 1% versus 11 ± 2%), l-selectinlo 
Figure 2.  Infl  ammatory status of host determines pathogenicity 
and phenotype of MLN lymphocytes. Flow cytometry was performed 
on MLN lymphocyte populations in SAMP (n = 3), AKR (n = 3), AKR 
BM → SAMP (n = 7), and SAMP BM → AKR (n = 6) mice. (A) Repre-
sentative T cell–gated (CD4+CD8+) dotplots of CD4 (y) versus CD69 (x) 
expression, with percentages of CD4+ T cells that are CD69+. (B) Repre-
sentative dotplots of B220 (x) versus IgA (y) expression, with averages of 
IgA+B220hi mature B cells and IgA+B220int plasmablasts as a percentage 
of all lymphocytes. Results are expressed as mean ± SEM. *Indicates 
signifi  cantly increased (P < 0.05) compared with AKR or SAMP BM → AKR 
mice. Lymphocyte subsets that were signifi  cantly increased in SAMP 
(x) versus AKR (y) mice included the percentage of IgA+ cells (◆) and 
the percentage of CD4+ T cells that were αE
+ (△), β7
hi (□), CD25+ (●), 
CD44hi (▲), CD69+ (◇), and L- selectinlo (■) (C, left). Similar trends were 
seen in a plot of SAMP BM → AKR (y) versus AKR BM → SAMP (x) 
subsets (C, right). The slopes of the best-fi  t lines through the points 
in the two plots were not signifi  cantly different. JEM VOL. 203, March 20, 2006  545
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(33 ± 6% versus 14 ± 2%), and CD44hi (28 ± 2 versus 19 ± 
3%) (Fig. 2 C). Plotting the size of each of these lymphocyte 
populations in SAMP on the x axis relative to the size in AKR 
mice on the y axis, the best-fi  t linear regression through these 
points has a slope that is not signifi  cantly diff  erent from the 
linear regression of sizes of the same populations in a plot of 
AKR BM → SAMP on the x axis versus SAMP BM → AKR 
on the y axis (Fig. 2 C). In contrast, the slope of the regression 
line through these points when SAMP BM → AKR is plotted 
on the x axis and AKR BM → SAMP size is plotted on the 
y axis is signifi  cantly diff  erent (P < 0.05) compared with the 
slope of the regression line on the SAMP (x) versus AKR (y) 
plot. These data strongly suggest that the overall MLN com-
position of AKR BM → SAMP mice closely resembles that 
seen in SAMP mice, though most MLN cells in AKR BM →
SAMP are derived from AKR mice. Likewise, the MLN 
composition of SAMP BM → AKR mice resembles that seen 
in AKR mice.
The aforementioned fi   ndings show that SAMP MLN 
lymphocyte population size is determined by the infl  amma-
tory status of the host and not by an intrinsic property of the 
lymphocytes themselves. Previous studies have shown that 
SAMP MLN CD4+ T cells express more IFNγ and TNF 
than do AKR MLN CD4+ T cells (36). To test whether the 
above redistribution of MLN lymphocyte subset size accord-
ing to recipient infl   ammatory status is accompanied by a 
change in the infl  ammatory potential of SAMP- and AKR-
derived CD4+ T cells, we measured cytokine expression in 
MLN CD4+ T cells cultured for 48 h in the presence of anti-
CD3 stimulation (Fig. 3). Consistent with previous fi  ndings, 
SAMP MLN CD4+ T cells exhibit an overall pattern of 
higher levels of cytokine production when compared with 
the cytokine profi  le of AKR cells. Compared with SAMP 
BM → AKR cells, AKR BM → SAMP CD4+ T cells pro-
duced signifi  cantly more TNF and IFNγ, with the average 
expression being greater than 18- and 130-fold higher, re-
spectively, in AKR BM → SAMP mice. AKR BM → SAMP 
cells also produce 15-fold higher levels of IL-2 than that pro-
duced by SAMP BM → AKR cells, suggesting that AKR 
BM → SAMP CD4+ T cells may proliferate at a higher rate 
than SAMP BM → AKR cells. Furthermore, whereas SAMP 
BM → AKR produce little or no IL-4 and IL-5, AKR BM → 
SAMP T cells produce signifi  cantly greater amounts of both 
of these cytokines (P < 0.05), suggesting that T cells derived 
from AKR BM are capable of orchestrating both the Th1 
and Th2 infl  ammatory responses that have been observed 
in native SAMP ileitis (37, 40). Interestingly, AKR BM → 
SAMP CD4+ T cells produce even higher levels of cytokines 
than native SAMP T cells, which may account for the in-
creased infl  ammatory scores in AKR BM → SAMP versus 
native SAMP mice. Although SAMP BM → AKR cells 
  produce signifi   cantly higher IFNγ compared with levels 
  produced by native AKR cells, overall diff  erences in cyto-
kine expression pattern between these two groups, measured 
by two-way ANOVA, were not signifi  cantly  diff  erent. 
  Increased cytokine expression by native SAMP and AKR 
BM → SAMP MLN CD4+ T cells is not simply caused by glo-
bal increases in bacterial translocation to the MLN in these mice, 
as there are no diff  erences in bacterial load within the MLN of 
native SAMP versus AKR MLN or among the MLN from each 
of the transplant recipient groups (unpublished data).
SAMP and AKR BM → SAMP mice exhibit epithelial 
barrier dysfunction
To investigate whether epithelial dysfunction may be re-
sponsible for the nonhematopoietic ileitis susceptibility trait 
in SAMP mice, we measured ileal epithelial permeability to 
charged ions in ilea of experimental mice using a previously 
described transepithelial electrical resistance (TEER) assay   
(44). Although ilea from AKR mice maintained their base-
line TEER after 1 h of culture (∆TEER at 1 h, 2 ± 3 Ω.cm2, 
mean ± SEM), SAMP ilea exhibited a substantial drop in 
TEER during the same time period (−8 ± 1 Ω.cm2), sug-
gesting that SAMP epithelium may not be able to maintain 
an eff  ective permeability barrier (Fig. 4 A, left). Ilea from 
AKR BM → SAMP mice also exhibited a decrease in TEER 
at 1h (−5 ± 1 Ω.cm2), whereas SAMP BM → AKR ilea 
maintained their baseline TEER levels (0 ± 1 Ω.cm2), sug-
gesting that the epithelial permeability defect in SAMP mice 
is not dependent on the specifi  c attributes or factors produced 
preferentially by SAMP hematopoietic cells.
Figure 3.  Increased cytokine expression in MLN CD4+ T cells from 
AKR BM → SAMP mice. Levels of secreted TNF, IFNγ, IL-2, IL-4, and IL-5 
were measured in triplicate by cytometric bead array, from 48-h cultures 
of AKR (□, n = 3), SAMP (■, n = 4), SAMP BM → AKR (△, n = 3), and 
AKR BM → SAMP (▲, n = 4) MLN CD4+ T cells (105/well), stimulated with 
immobilized anti-CD3 antibody. Points represent individual mice with the 
mean value (_) in each group also shown. *Signifi  cantly increased 
compared with SAMP BM → AKR cells (P < 0.05).546  PRIMARY NONHEMATOPOIETIC SOURCE FOR CHRONIC ILEITIS | Olson et al. 
Increased epithelial permeability was also seen in the je-
junum of native SAMP (−9 ± 2) versus native AKR (14 ± 
7), though no diff  erences in ∆TEER were seen among the 
four transplant recipient groups (Fig. 4 A, right). No jejunal 
infl  ammation was detectable in native SAMP mice or in any 
of the transplant recipient groups. The discrepancy between 
the presence of the epithelial permeability defect in both je-
junum and ileum and the restriction of infl  ammation to the 
ileum in native SAMP mice may be explained by diff  eren-
tial bacterial load, as SAMP ileal bacterial load was increased 
>10-fold compared with jejunum (unpublished data). Given 
that infl  ammation in native SAMP mice is decreased by anti-
biotic treatment (40) and that infl  ammation in transplant re-
cipients can be reduced > 70% by continuous posttransplant 
antibiotic therapy (unpublished data), the high bacterial load 
present in the ileum is likely required, along with epithelial 
barrier dysfunction, to initiate infl  ammation.
To examine epithelial permeability in vivo and to de-
termine the specifi  c sites along the gastrointestinal tract that 
may display an epithelial permeability defect in SAMP and 
AKR BM → SAMP mice, we gave AKR BM → SAMP 
and SAMP BM → AKR mice an orogastric gavage of a 
disaccharide probe containing sucrose, lactulose, mannitol, 
and sucralose before and for several weeks after BMT. We 
then analyzed the fractional excretion (FE) of these sugars 
in the 24-h period after probe administration to determine 
epithelial permeability in specifi  c regions in the gastroin-
testinal tract as previously described (45). Before receiv-
ing irradiation and BM transplant, SAMP mice (AKR BM 
→ SAMP, time 0) had elevated lactulose to mannitol FE 
ratios relative to AKR mice (SAMP BM → AKR, time 
0) (lactulose FE/mannitol FE, 0.44 ± 0.02 versus 0.28 ± 
0.02, mean ± SEM), indicative of increased small intesti-
nal epithelial permeability in SAMP mice (Fig. 4 B, left). 
AKR BM → SAMP mice also displayed increased epithelial 
permeability in the small intestine relative to SAMP BM 
→ AKR mice both 3 wk (0.47 ± 0.03 versus 0.37 ± 0.02, 
mean ± SEM) and 6 wk (0.41 ± 0.02 versus 0.32 ± 0.03) 
after transplant. In contrast, no diff  erences were measured 
in the FE of sucralose, an indicator of colonic permeability, 
among SAMP, AKR, AKR BM → SAMP, and SAMP → 
AKR mice (Fig. 4 B, right).
Increased epithelial permeability precedes the onset 
of infl  ammation and is present in the absence of bacterial 
Figure 4.  Epithelial barrier dysfunction in SAMP and AKR BM 
→ SAMP mice. (A) TEER assays on ileum and jejunum from SAMP (n = 8), 
AKR (n = 8), SAMP BM → SAMP (n = 5), AKR BM → SAMP (n = 4), AKR 
BM → AKR (n = 3), and SAMP BM → AKR (n = 4) mice. Ilea from SAMP, 
SAMP BM → SAMP, and AKR BM → SAMP mice exhibited decreases in 
∆TEER indicative of increased epithelial permeability, whereas ilea from 
AKR, AKR BM → AKR, and SAMP BM → AKR mice maintained an effective 
epithelial resistance barrier. Signifi  cant differences (P < 0.03) are indi-
cated between experimental groups (A, left). No differences were observed 
in jejunal TEER among BMT recipient groups. A signifi  cant in crease in 
TEER was seen in native SAMP compared with AKR jejunum; P < 0.03 (A, 
right). (B) In vivo assays measuring epithelial permeability to solutes in the 
small intestine and colon using urinary FE ratio of lactulose to mannitol 
(B, left) and of sucralose (B, right), respectively, in AKR BM → SAMP (◆) 
(n = 6) and SAMP BM → AKR (■) (n = 6) mice. The time 0 point was col-
lected immediately before irradiation and transplantation and thus repre-
sent the permeability of native SAMP (◆) and AKR (■) tissues. *Indicates 
signifi  cantly increased (P < 0.05) compared with SAMP BM → AKR mice.JEM VOL. 203, March 20, 2006  547
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  colonization in SAMP mice. The epithelial barrier defect was 
further characterized by measuring intestinal epithelial per-
meability using the aforementioned in vivo disaccharide 
probe method in native SAMP and AKR mice beginning at 
3 wk of age, immediately after weaning, and continuing at 
specifi  ed intervals through 20 wk of age. SAMP mice exhib-
ited a 1.6-fold higher small intestinal permeability than age-
matched AKRs throughout the time course studied (Fig. 5 A, 
left), with the increased permeability relative to AKR present 
even at the earliest time point assayed. In a parallel time 
course study measuring total ileal infl  ammation by histologic 
score (Fig. 5 B, left) and acute infl  ammation/neutrophil infi  l-
tration by myeloperoxidase (MPO) assay (Fig. 5 C, left), 3-
wk-old SAMP ilea displayed no histologic evidence of 
in  fl  ammation and only low levels of MPO activity that were 
not greater than levels measured in 3-wk-old AKR ilea. Fur-
thermore, infl  ammatory scores and MPO activity were not 
considerably greater in SAMP compared with AKR mice 
until after 6 wk of age. Thus, increased epithelial permeabil-
ity precedes the development of infl  ammation in SAMP mice 
by at least 3 wk. In contrast to the small intestine, no diff  er-
ences in AKR versus SAMP colonic permeability were seen 
at any age studied, and neither SAMP nor AKR mice dis-
played histologically detectable colitis or high levels of MPO 
activity throughout this time course (Fig. 5, A–C, right).
Small intestinal permeability in 3-wk-old SAMP mice 
raised under GF conditions was nearly identical to that in 
age-matched SAMPs raised under specifi  c  pathogen-free 
(SPF) conditions (0.40 ± 0.06 vs. 0.41 ± 0.02, NS), but sig-
nifi  cantly greater than (1.55-fold) small intestinal permeabil-
ity in age-matched, SPF-raised AKR mice (0.26 ± 0.01, P < 
0.05) (Fig. 6 A). Mice from all of these groups displayed nor-
mal bowel wall architecture with histologic infl  ammatory 
scores close to zero (Fig. 6). Thus, increased epithelial per-
meability in SAMP mice occurs independently from coloni-
zation with commensal bacteria.
Figure 5.  Increased small intestinal permeability occurs before the 
onset of infl  ammation in SAMP mice. (A) Paracellular permeability, 
measured in the small intestine and colon using the in vivo probe assay, 
was increased as early as 3 wk of age in SAMP (□) compared with age-
matched AKR (■) mice, and remained elevated through 20 wk. (B) Total 
infl  ammatory scores for the ileum and colon show that   infl  ammation 
was not signifi  cantly increased in SAMP versus AKR ileum until 12 wk 
of age. (C) Ileal MPO activity, providing a quantitative marker of active 
infl  ammation, showed a strong correlation with histologic ileal infl  am-
matory score (r = 0.77) and was also not increased in SAMP   versus 
AKR mice until 12 wk. n ≥ 4 per group; *P < 0.05 versus 
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Altered TJ protein expression in SAMP ileum accompanies 
epithelial permeability defect
To begin to elucidate potential mechanism(s) underlying the 
epithelial permeability defect in SAMP ileum, expression of 
TJ-associated ZO-1, claudin-1, -2, -3, and -4, and occludin 
was characterized in 3-wk-old SAMP and AKR mice. Im-
munohistochemical examination of ZO-1 in SAMP ileum 
and colon demonstrated perijunctional staining with no no-
table diff  erences in ZO-1 staining compared with AKR con-
trols (unpublished data). Claudin-1, -3 and -4 mRNA levels 
were expressed at comparable levels in isolated epithelial cells 
from 3-wk-old SAMP versus AKR ileum as well as colon 
(Fig. 7). Claudin-2 mRNA expression, however, was found 
to be more than eightfold greater in SAMP versus AKR il-
eum. Although an increased trend in claudin-2 mRNA ex-
pression was observed in SAMP versus AKR colon, this 
increase was not statistically diff  erent. Conversely, an  1.8-
fold decrease in occludin expression was found in SAMP 
  versus AKR ileum as well as colon (Fig. 7). These data suggest 
that although decreased expression of occludin is present in 
both the ileum and colon of SAMP compared with AKR, 
the epithelial permeability defect may be heightened in com-
bination with the high levels of claudin-2 expression in the 
ileum, but not the colon, of SAMP mice.
DISCUSSION
The presence of severe ileitis in SAMP mice reconstituted 
with AKR BM, but not in AKR mice reconstituted with 
SAMP BM, demonstrates that the primary factor responsible 
for the induction of ileitis in SAMP mice originates within a 
nonhematopoietic tissue. As a corollary, this fi  nding also es-
tablishes that AKR hematopoietic cells transplanted into 
SAMP do not prevent ileitis, but rather orchestrate an ileal 
infl  ammatory response with similar severity to that produced 
by SAMP hematopoietic cells, confi  rming previous results 
suggesting that SAMP ileitis is not caused by defects in SAMP 
Figure 6.  Early, preinfl  ammatory alterations in small intestinal 
barrier function persist in the absence of the enteric fl  ora. (A) Small 
intestinal paracellular permeability in GF SAMP mice was similar to per-
meability in SAMP mice raised under SPF conditions, and signifi  cantly 
  increased compared with SPF-AKR permeability n ≥ 4 per group; *P < 0.05 
versus age-matched AKR. (B) 3-wk-old GF SAMP mice displayed no 
histological signs of ileal infl  ammation and possessed normal 
intestinal architecture.
Figure 7.  Altered epithelial TJ protein expression in young, unin-
fl  amed SAMP compared with AKR mice. mRNA transcript levels of TJ 
proteins (claudin [CLDN] 1–4 and occludin) were measured by RT-PCR and 
expressed relative to HGPRT in isolated intestinal epithelial cell prepara-
tions from the ileum (left) or colon (right) of SAMP and AKR mice (3 wk of 
age; n ≥ 4 animals per group). The greatest differences in expression in 
SAMP ileum compared with age-matched AKR controls were seen in 
CLDN2 (eightfold increase; top left) and occludin (1.8-fold decrease; 
bottom left). Similar trends were seen in the colon, though increases in 
CLDN2 (top right) expression in SAMP versus AKR colon were not statisti-
cal signifi  cant. No differences in expression were noted for CLDN1, 3, and 
4 in either the ileum or colon of SAMP relative to controls. n ≥ 4 per 
group; *P < 0.05 versus control AKR.JEM VOL. 203, March 20, 2006  549
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regulatory T cell function (38). Further, we have demon-
strated that when transplanted into SAMP mice, certain 
  subpopulations of AKR MLN lymphocytes expand to ap-
proximate the sizes of these populations in SAMP mice. 
Many of these subsets, including αE
+ CD4+ T cells and 
CD25+ CD4+ T cells may represent activated and/or regula-
tory T cell populations (38). Therefore as demonstrated in 
our previous studies, it is possible that, like SAMP regulatory 
cells, AKR regulatory cells may expand as part of a futile 
compensatory eff  ort to curb ileal infl  ammation characteristic 
of SAMP mice.
In addition to regulatory cell expansion, some AKR CD4+ 
T cells in AKR BM → SAMP mice also acquire increased 
pathogenicity, because they not only participate in the severe 
infl  ammation seen in AKR BM → SAMP mice, but they 
also transfer signifi  cantly more severe ileitis to SCID mice 
than do CD4+ T cells from native AKR mice (unpublished 
data). This pathogenicity is likely linked to the elevated cy-
tokine production exhibited by AKR-derived CD4+ T cells 
in AKR BM → SAMP mice. Interestingly, SAMP CD4+ 
T cells from SAMP BM → AKR mice still transfer ileitis to 
SCID mice, despite the fact that these cells don’t produce 
ileitis in SAMP BM → AKR mice themselves (unpublished 
data). One possible explanation for this discrepancy is that 
the small population of mature CD4+ T cells present in BM 
(46) may have been transplanted into AKR mice along with 
SAMP hematopoietic stem cells, and that the progeny of this 
preprogrammed infl  ammatory population may be present in 
the MLN CD4+ T cell population transferred to SCID mice. 
Alternatively, SAMP T cells may possess intrinsically more 
potent ileitis-producing capacity than AKR T cells and are 
thus still able to induce ileitis in SCID mice even after under-
going reeducation in AKR mice. Regardless, CD4+ T cells 
from SAMP BM → AKR mice produce low overall levels 
of cytokines similar to that produced by native AKR CD4+ 
T cells. Thus, if SAMP-derived CD4+ T cells do possess in-
creased ileitis-promoting capacity, this capacity appears to be 
suppressed in the AKR host and must be reacquired upon 
transfer of these SAMP-derived cells from AKR to SCID 
mice. Thus, the nonhematopoietic-derived resistance to il-
eitis in AKR mice is dominant over any leukocyte-derived 
susceptibility. Given previous reports of epithelial dysfunc-
tion caused by the defi  cient immune system in SCID mice 
(47), we speculate that SCID mice may also possess a non-
hematopoietic ileitis susceptibility factor, enabling transferred 
AKR BM → SAMP, SAMP BM → AKR, or native SAMP 
CD4+ T cells to induce severe infl  ammation.
The epithelial barrier defect seen in SAMP and AKR 
BM → SAMP mice suggests that epithelial cell dysfunction 
may be primarily responsible for the development of ileitis 
in this model. Because epithelial barrier dysfunction can be 
induced by proinfl  ammatory cytokines (48), it remains to be 
defi  nitively proven whether the epithelial permeability defect 
observed in SAMP mice is a cause or a consequence of ileitis 
in this model. For instance, TNF and IFNγ induce large in-
creases in intestinal permeability of intestinal epithelial cell lines 
through NF-κB transcriptional activation resulting in redistri-
bution of ZO-1, claudins, and occludin from the junctional 
interface to the cytoplasm (31, 48). However, we have shown 
that this permeability defect is not dependent on strain-specifi  c 
proinfl  ammatory properties of SAMP leukocytes, as AKR 
BM → SAMP mice also exhibit this epithelial permeability 
  defect. Furthermore, considerable epithelial barrier dysfunc-
tion was found even in 3-wk-old SAMP mice, an age by which 
ileal infl  ammation has not yet developed, providing convincing 
evidence in favor of the primacy of barrier dysfunction as an 
etiologic factor in SAMP ileitis. Interestingly, colonic epithe-
lium exhibited normal barrier function compared with WT 
mice, a fi  nding that may explain the lack of colonic infl  am-
mation in this model. Native SAMP jejunal epithelium does 
appear to possess the permeability defect, though the lower 
bacterial load in the jejunum versus the ileum may explain 
why infl  ammation is primarily limited to the ileum.
Barrier dysfunction can also be produced directly by both 
pathogenic and commensal bacterial through a variety of 
mechanisms. For example, enteropathogenic E. coli induces 
dephosphorylation and tight junctional dissociation of occludin 
thereby increasing permeability (30). However, unlike other 
models of infl  ammatory bowel disease such as the IL-10−/− 
model, in which commensal fl  ora interactions are required for 
increases in colonic permeability that precede infl  ammatory 
changes (49), our study shows that increased ileal epithelial 
permeability in SAMP mice occurs to the same extent in GF 
animals without evidence of colonization. Importantly, de-
fects intrinsic to other cell types, such as stromal cells, that also 
play roles in modulating epithelial permeability (27) could also 
cause this barrier defect and through cell–cell interactions may 
cause the altered TJ membrane protein expression observed in 
SAMP mice. Additionally, we cannot exclude involvement of 
residual recipient macrophages and dendritic cells in the ileitis 
seen in AKR → SAMP mice. However, the ileitis in SAMP 
mice is unlikely to result from intrinsic properties of these 
antigen-presenting cells, because these cells are incapable of 
producing infl  ammation in SAMP BM → AKR mice.
SAMP ilea possess many abnormalities in epithelial ap-
pearance and composition that have been previously reported 
(34). Further studies demonstrated markedly expanded and 
aberrant rearrangement of secretory lineage Paneth and goblet 
cell populations in SAMP ileum (36), similar to epithelial phe-
notype changes observed in human CD (50), which may con-
tribute to increased epithelial permeability. Data in the present 
study demonstrate that TJ protein expression is also altered 
in SAMP versus AKR ileum. Although barrier dysfunction 
produced by infection in vivo (51) or infl  ammatory mediators 
in vitro (31) involves relocalization of ZO-1, no abnormal lo-
calization of ZO-1 was noted in SAMP ileum, suggesting that 
the high epithelial permeability in SAMP mice may not be 
caused by reorganization of cytoskeletal connections with TJs. 
Global decreases in intestinal occludin mRNA and protein 
expression have been observed in CD patients (52). Given the 
fact that down-regulation of occludin has been shown to in-
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occludin expression we have observed in SAMP versus AKR 
ileum may contribute to barrier dysfunction in SAMP mice. 
Although high levels of occludin and some claudin isoforms 
enhance epithelial barrier function through stabilization of TJs, 
increased claudin-2 expression has been shown in an in vitro 
transfection system to increase epithelial permeability, possibly 
by forming lower affi   nity interactions with other claudin iso-
forms on neighboring cells (28). Thus, the increased claudin-
2 expression by SAMP versus AKR epithelial cells may also 
contribute to the defective barrier phenotype.
In conclusion, we have demonstrated that the primary 
susceptibility leading to the development of ileitis in SAMP 
mice is derived from a nonhematopoietic source, as SAMP 
BM progenitor cells do not transmit this ileitis phenotype 
when transplanted into AKR mice. Further, we have shown 
that hematopoietic cells from normal mice transplanted into 
SAMP mice can fully orchestrate this ileal infl  ammatory re-
sponse in the presence of this nonhematopoietic susceptibil-
ity, acquire surface phenotypes similar to cells seen in native 
SAMP, and undergo maturation and reeducation such that T 
cells derived from these AKR cells express high levels of in-
fl  ammatory cytokines. Epithelial barrier dysfunction in native 
SAMP mice and SAMP mice reconstituted with AKR BM 
suggests that the epithelium may be responsible for this non-
hematopoietic ileitis susceptibility, as barrier dysfunction pre-
cedes infl  ammation development by > 3 wk and occurs in 
the absence of bacterial colonization. This barrier dysfunc-
tion may result from dysregulation of TJ proteins caused by 
aberrant intracellular signaling pathways possibly involving 
transcription factors such as Pparγ. Further studies that defi  n-
itively prove that epithelial-specifi  c dysfunction is the pri-
mary defect causing ileitis and uncover the specifi  c molecular 
mechanisms leading to loss of barrier integrity are warranted 
and may provide critical insights into the etiology of CD.
MATERIALS AND METHODS
Animal model. SAMP mice were propagated at the University of Virginia, 
with founders provided by S. Matsumoto (Yakult Central Institute for Mi-
crobiological Research, Tokyo, Japan), and originally derived from the 
AKR/J strain (Jackson Laboratories). SAMP and WT AKR mice were 
housed under SPF at the UVA. GF SAMP were derived and maintained at 
Taconic Farms (Rockville, MD), and shipped in sterile isolators and used in 
experiments upon arrival. All mice were maintained in accordance to ap-
proved protocols by the Institutional Animal Care and Use Committee and 
Association for Assessment of Laboratory Animal Care.
BM transplantation. Mice receiving BMT were irradiated (600 RAD) on 
the morning of transplantation and 4–6 h later, immediately before trans-
plantation. BM was harvested from femurs and tibias of 6-wk-old SAMP or 
AKR mice with RPMI (10% FCS), and cell suspensions washed and diluted 
to a concentration of 30 × 106 cells/ml in HBSS. 7.5 × 106 cells/250 μl 
were injected i.v. into the lateral tail veins of recipient mice. BMT mice 
were placed on antibiotic water (0.7 mM neomycin sulfate, 80 mM sulfa-
methoxazole, and 0.37 mM trimethoprim) for 2 wk after irradiation, and 
then given autoclaved water to reconstitute normal gut fl  ora.
Histology. The distal 10 cm of ileum from experimental mice was removed, 
fl  ushed of fecal contents, opened longitudinally, and placed in Bouin’s fi  xa-
tive. Tissues were embedded in paraffi   n, cut to 3 μm, and stained with he-
matoxylin and eosin. Ileitis severity was assessed by a trained pathologist in a 
blinded fashion using an established histologic scoring system (43), wherein 
total infl  ammatory index represents the sum of three individual indices: ac-
tive infl  ammation, chronic infl  ammation, and villous distortion as described 
in detail elsewhere (43).
Flow cytometry. MLN from experimental mice were homogenized 
through 70-μm strainers into PBS containing 2% FBS. 106 cells/sample 
were stained with combinations of FITC-, PE-, PERCP-, and APC-labeled 
hamster anti–mouse CD69 (H1.2F3) and rat anti–mouse CD4 (RM4-5), 
CD19 (1D3), B220 (RA3-6B2), IgA (C10-3), αE integrin (M290), β7 integ-
rin (M293), CD25 (PC61), CD44 (IM7), and l-selectin (MEL-14) (BD 
PharMingen). Excess antibody was removed and cells fi  xed in 2% parafor-
maldehyde before analysis by FACS, with postrun data analyzed using 
  WinMidi 2.8 (Trotter).
Cell culture. CD4+ T cells from experimental mice were cultured in 96-
well plates coated with anti–mouse CD3 (1 μg/ml, clone 145-2C11; BD 
PharMingen) at 37°C with 5% CO2 in RPMI (10% FCS, 100 U/ml penicil-
lin, 100 μg/ml streptomycin, 1 mM sodium pyruvate, 1 mM nonessential 
amino acids, 50 μM 2β-mercaptoethanol) for 48 h at 105 cells/well in 100 μl. 
Undiluted supernatants were assayed for TNF, IFNγ, IL-2, IL-4, and IL-5 
using the mouse Th1/Th2 cytokine kit (BD PharMingen) according to 
manufacturer’s instructions.
Ex vivo permeability. TEER assays were performed after a previously 
published method (44). In brief, distal ilea from experimental mice were re-
moved, fl  ushed with 0.9% NaCl, and opened longitudinally to expose mu-
cosal surfaces. Two 3-mm squares of tissue were excised and placed apical 
side up on separate precut and wetted 0.4-μm pore size membranes (Costar 
Corning Inc.). Specimens were mounted between two custom made Plexi-
glass discs with laser cut holes (2-mm diameter) to expose apical and basolat-
eral tissue surfaces, inserted into a Snapwell (Costar) apical side up, and fi  tted 
into a 6-well plate with 3 ml DMEM (glutamine, nonessential amino acids, 
100 U/ml penicillin, and 100 μg/ml streptomycin) added basally and 300 μl 
apically. TEER readings were taken using an EVOM voltmeter with an 
  EndOhm chamber attachment (World Precision Instruments) immediately 
after assembling transwell apparati and after 1 h incubation at 37°C. Baseline 
resistance readings were determined in transwells containing membrane 
  inserts only and subtracted from sample values.
In vivo permeability. Experimental mice were assayed in vivo for intesti-
nal permeability using a previously established method (45, 51). In brief, 
mice were fasted for 2 h before oral gavage of disaccharide permeability 
probes (500 mg/ml sucrose, 60 mg/ml lactulose, 40 mg/ml mannitol, 30 
mg/ml sucralose in 0.2 ml water), and placed into individual metabolic cages 
(Nalge Nunc Int.) for 22 h to allow for urine collection, which was gravi-
metrically determined and recorded. Concentration of sucrose, lactulose, 
and mannitol in specimens was determined by pulsed amperometric detec-
tion using a Dionex HPLC with MA-1 columns (Dionex) and NaOH-based 
elution (45). Similarly, sucralose concentrations were determined using 
Dionex Ionpac NS1 columns (Dionex) and a gradient of acetonitrile in water 
as the eluent for HPLC analysis (45). Data were expressed as urinary FE.
MPO assay. Ileum and colon samples were assayed for MPO activity as pre-
viously described (53, 54). Specimens were collected, weighed, diluted 20-
fold in 0.5% HTAB buff  er, homogenized with a Polytron PT 10–35 tissue 
homogenizer (Kinematica), and centrifuged to pellet debris. Samples (7 μL) 
were loaded in triplicate into a 96-well plate and exposed to substrate solu-
tion (200 μL; 5 mM potassium phosphate buff  er containing 0.0005% H2O2 
and 0.167 mg/ml O-dianisidine). The average rate of absorbance change at 
450 nm over 2 sequential 30-s intervals was used to calculate MPO activity.
mRNA expression of TJ proteins. Expression of occludin and claudins-
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hypoxanthine-guanine phosphoribosyl transferase (HGPRT; housekeeper) 
was performed using the following primers: occludin sense (5′-C  C  C  T  G-
A  C  C  A  C  T  A  T  G  A  A  A  C  A  G  -3′) and antisense (5′-T  T  G  A  T  C  T  G  A  A  G  T  G  A-
T  A  G  G  T  G  -3′); claudin-1 sense (5′-A  C  G  G  T  C  T  T  T  G  C  A  C  T  T  T  G  G  T  -3′) 
and antisense (5′-A  G  T  T  T  G  C  A  G  G  A  T  C  T  G  G  G  A  T  -3′); claudin-2 sense 
(5′-T  A  T  C  T  G  T  G  T  G  G  T  G  G  G  C  A  T  G  A  -3′) and antisense (5′-C  G  A  A  G  G  A-
T  G  C  C  A  T  G  A  A  G  A  T  T  -3′); claudin-3 sense (5′-C  C  A  C  T  A  C  C  A  G  C  A  G  T-
C  G  A  T  G  A  -3′) and antisense (5′-C  A  G  C  C  T  G  T  C  T  G  T  C  C  T  C  T  T  C  C  -3′); 
claudin-4 sense (5′-A  G  C  A  A  A  C  G  T  C  C  A  C  T  G  T  C  C  T  T  -3′) and antisense 
(5′-C  C  C  T  C  A  T  C  A  G  T  C  A  C  T  C  A  G  C  A  -3′); and HGPRT sense (5′-T  G  C-
C  G  A  G  G  A  T  T  T  G  G  A  A  A  A  A  G  T  G  -3′) and antisense (5′-C  A  C  A  G  A  G  G  G  C  C-
A  C  A  A  T  G  T  G  A  T  G  -3′). Real-time PCR was performed using a Bio-Rad 
iCycler iQ Real Time Detection system and software (Bio-Rad Laborato-
ries). Reaction mixture consisted of fi  nal concentrations of 1× PCR buff  er, 
200 μM dATP, dCTP, dGTP, and dTTP, 3 mM MgCl2, 0.5 U Platinum 
Taq polymerase, and 400 nM of each primer in a 25 μl volume. Thermal 
cycling conditions were 95°C/2 min followed by 40 cycles of 95°C/15 s, 
60°C/15 s, and 72°C/15 s. Expression of occludin and claudins-1 through 
−4 were normalized to HGPRT mRNA.
Statistics. Statistical analysis was performed using the two-tailed Student’s 
t test, with statistical signifi  cance set at P < 0.05. Coeffi   cients of determina-
tion, R2, were determined by linear regression. Statistical comparison of the 
slopes of linear regression correlations was performed using the formula: 
t statistic = (b1−b2)/S(b1−b2), where b1 and b2 are the slopes of the lines 
and S(b1−b2) is the standard error of the diff  erence of the regression slopes. 
This t statistic was compared with the critical t stat for the relevant degrees 
of freedom using P < 0.05 to determine signifi  cance. Statistical comparisons 
of cytokine expression were performed using two-way analysis of variance 
on ranks (Friedman’s Test), using mouse strain as one factor and cytokine 
expression as the other factor. The Holm-Sidak adjustment for multiple 
comparisons was then used to make pairwise comparisons between mouse 
strains in terms of individual cytokine production.
The authors would like to acknowledge Drs. Christopher Moskaluk and James Mize 
for histopathologic evaluation, Kim Tran for HPLC analysis, William Ross for fl  ow 
cytometry expertise, Matt Staples, Angela Best, Anthony Bruce, and Robert Knight 
for technical assistance, and Dr. Satoshi Matsumoto for providing original 
SAMP1/Yit breeding pairs.
This work was supported by National Institutes of Health P01DK57880 
(to F. Cominelli, S.M. Cohn, K.F. Ley, and T.T. Pizarro), R01DK56762 (to T.T. Pizarro), 
K26RR00175 (to P.B. Ernst), GM07267-23 (University of Virginia to T.S. Olson), and 
the Morphology/Imaging (Sharon Hoang and Greg Harp) and Immunology Cores of 
the National Institutes of Health-funded Silvio O. Conte Digestive Diseases Research 
Center at University of Virginia, P30DK56703 (to F. Cominelli/T.T. Pizarro and 
F. Cominelli/P.B. Ernst). Additional support was provided by the Crohn’s & Colitis 
Foundation of America (to B.K. Reuter), and a Fellowship from the Canadian Association 
of Gastroenterologists and Canadian Institute for Health Research (to K.G-E. Scott).
The authors have no confl  icting fi  nancial interests.
Submitted: 22 February 2005
Accepted: 26 January 2006
REFERENCES
 1. Bouma, G., and W. Strober. 2003. The immunological and genetic 
basis of infl  ammatory bowel disease. Nat. Rev. Immunol. 3:521–533.
 2. Egan, L.J., and W.J. Sandborn. 2004. Advances in the treatment of 
Crohn’s disease. Gastroenterology. 126:1574–1581.
 3  Ma, T.Y. 1997. Intestinal epithelial barrier dysfunction in Crohn’s dis-
ease. Proc. Soc. Exp. Biol. Med. 214:318–327.
  4.  Shanahan, F. 2002. Crohn’s disease. Lancet. 359:62–69.
 5. Ogura, Y., N. Inohara, A. Benito, F.F. Chen, S. Yamaoka, and G. 
Nunez. 2001. Nod2, a Nod1/Apaf-1 family member that is restricted to 
monocytes and activates NF-kappaB. J. Biol. Chem. 276:4812–4818.
  6.  Hisamatsu, T., M. Suzuki, H.C. Reinecker, W.J. Nadeau, B.A. McCormick, 
and D.K. Podolsky. 2003. CARD15/NOD2 functions as an antibacterial 
factor in human intestinal epithelial cells. Gastroenterology. 124:993–1000.
 7. Monteleone, G., L. Biancone, R. Marasco, G. Morrone, O. Marasco, 
F. Luzza, and F. Pallone. 1997. Interleukin 12 is expressed and actively 
released by Crohn’s disease intestinal lamina propria mononuclear cells. 
Gastroenterology. 112:1169–1178.
 8. Fuss, I.J., M. Neurath, M. Boirivant, J.S. Klein, C. de la Mott, S.A. 
Strong, C. Fiocchi, and W. Strober. 1996. Disparate CD4+ lamina pro-
pria (LP) lymphokine secretion profi  les in infl  ammatory bowel disease. 
Crohn’s disease LP cells manifest increased secretion of IFN-gamma, 
whereas ulcerative colitis LP cells manifest increased secretion of IL-5. 
J. Immunol. 157:1261–1270.
 9. Mottet, C., H.H. Uhlig, and F. Powrie. 2003. Cutting edge: cure 
of colitis by CD4(+)CD25(+) regulatory T cells. J. Immunol. 170:
3939–3943.
10. Powrie, F., M.W. Leach, S. Mauze, L.B. Caddle, and R.L. Coff  man. 
1993. Phenotypically distinct subsets of CD4+ T cells induce or pro-
tect from chronic intestinal infl  ammation in C. B-17 scid mice. Int. 
Immunol. 5:1461–1471.
11. Singh, B., S. Read, C. Asseman, V. Malmstrom, C. Mottet, L.A. 
Stephens, R. Stepankova, H. Tlaskalova, and F. Powrie. 2001. Control 
of intestinal infl  ammation by regulatory T cells. Immunol. Rev. 182:
190–200.
12.  Kraus, T.A., L. Toy, L. Chan, J. Childs, and L. Mayer. 2004. Failure to 
induce oral tolerance to a soluble protein in patients with infl  ammatory 
bowel disease. Gastroenterology. 126:1771–1778.
13. Duchmann, R., I. Kaiser, E. Hermann, W. Mayet, K. Ewe, and K.H. 
Meyer zum Buschenfelde. 1995. Tolerance exists towards resident 
intestinal fl  ora but is broken in active infl  ammatory bowel disease (IBD). 
Clin. Exp. Immunol. 102:448–455.
14. Kazemi-Shirazi, L., C.H. Gasche, S. Natter, A. Gangl, J. Smolen, S. 
Spitzauer, P. Valent, D. Kraft, and R. Valenta. 2002. IgA autoreactivity: 
a feature common to infl  ammatory bowel and connective tissue diseases. 
Clin. Exp. Immunol. 128:102–109.
15. Dohi, T., K. Fujihashi, T. Koga, Y. Shirai, Y.I. Kawamura, C. Ejima, 
R. Kato, K. Saitoh, and J.R. McGhee. 2003. T helper type-2 cells in-
duce ileal villus atrophy, goblet cell metaplasia, and wasting disease in 
T cell-defi  cient mice. Gastroenterology. 124:672–682.
16. Dieckgraefe, B.K., and J.R. Korzenik. 2002. Treatment of active 
Crohn’s disease with recombinant human granulocyte-macrophage 
colony-stimulating factor. Lancet. 360:1478–1480.
17. Lopez-Cubero, S.O., K.M. Sullivan, and G.B. McDonald. 1998. 
Course of Crohn’s disease after allogeneic marrow   transplantation. 
Gastroenterology. 114:433–440.
18.  Cario, E., and D.K. Podolsky. 2000. Diff  erential alteration in intestinal 
epithelial cell expression of toll-like receptor 3 (TLR3) and TLR4 in 
infl  ammatory bowel disease. Infect. Immun. 68:7010–7017.
19. Pizarro, T.T., M.H. Michie, M. Bentz, J. Woraratanadharm, M.F. 
Smith Jr., E. Foley, C.A. Moskaluk, S.J. Bickston, and F. Cominelli. 
1999. IL-18, a novel immunoregulatory cytokine, is up-regulated in 
Crohn’s disease: expression and localization in intestinal mucosal cells. 
J. Immunol. 162:6829–6835.
20.  Dwinell, M.B., P.A. Johanesen, and J.M. Smith. 2003. Immunobiology of 
epithelial chemokines in the intestinal mucosa. Surgery. 133:601–607.
21. Meddings, J. 2000. Barrier dysfunction and Crohn’s disease. Ann. NY 
Acad. Sci. 915:333–338.
22. Hollander, D., C.M. Vadheim, E. Brettholz, G.M. Petersen, T. 
Delahunty, and J.I. Rotter. 1986. Increased intestinal permeability in 
patients with Crohn’s disease and their relatives. A possible etiologic 
factor. Ann. Intern. Med. 105:883–885.
23. May, G.R., L.R. Sutherland, and J.B. Meddings. 1993. Is small intes-
tinal permeability really increased in relatives of patients with Crohn’s 
disease? Gastroenterology. 104:1627–1632.
24. Wyatt, J., H. Vogelsang, W. Hubl, T. Waldhoer, and H. Lochs. 1993. 
Intestinal permeability and the prediction of relapse in Crohn’s disease. 
Lancet. 341:1437–1439.
25.  Schneeberger, E.E., and R.D. Lynch. 2004. The tight junction: a mul-
tifunctional complex. Am. J. Physiol. Cell Physiol. 286:C1213–C1228.552  PRIMARY NONHEMATOPOIETIC SOURCE FOR CHRONIC ILEITIS | Olson et al. 
26.  Gewirtz, A.T., Y. Liu, S.V. Sitaraman, and J.L. Madara. 2002. Intestinal 
epithelial pathobiology: past, present and future. Best Pract. Res. Clin. 
Gastroenterol. 16:851–867.
27. Clayburgh, D.R., L. Shen, and J.R. Turner. 2004. A porous defense: 
the leaky epithelial barrier in intestinal disease. Lab. Invest. 84:282–291.
28. Furuse, M., K. Furuse, H. Sasaki, and S. Tsukita. 2001. Conversion 
of zonulae occludentes from tight to leaky strand type by introducing 
claudin-2 into Madin-Darby canine kidney I cells. J. Cell Biol. 153:
263–272.
29.  Turksen, K., and T.C. Troy. 2004. Barriers built on claudins. J. Cell Sci. 
117:2435–2447.
30.  Simonovic, I., J. Rosenberg, A. Koutsouris, and G. Hecht. 2000.
Enteropathogenic Escherichia coli dephosphorylates and dissociates occlu-
din from intestinal epithelial tight junctions. Cell. Microbiol. 2:305–315.
31. Ma, T.Y., G.K. Iwamoto, N.T. Hoa, V. Akotia, A. Pedram, M.A. 
Boivin, and H.M. Said. 2004. TNF-alpha-induced increase in intestinal 
epithelial tight junction permeability requires NF-kappa B activation. 
Am. J. Physiol. Gastrointest. Liver Physiol. 286:G367–G376.
32. Strober, W., I.J. Fuss, and R.S. Blumberg. 2002. The immunology of 
mucosal models of infl  ammation. Annu. Rev. Immunol. 20:495–549.
33. Crohn, B.B., L. Ginzburg, and G.D. Oppenheimer. 1932. Regional 
ileitis: a pathologic and clinical entity. 1932. Mt. Sinai J. Med. 99:
1323–1329.
34.  Matsumoto, S., Y. Okabe, H. Setoyama, K. Takayama, J. Ohtsuka, H. 
Funahashi, A. Imaoka, Y. Okada, and Y. Umesaki. 1998. Infl  ammatory 
bowel disease-like enteritis and caecitis in a senescence accelerated 
mouse P1/Yit strain. Gut. 43:71–78.
35. Rivera-Nieves, J., G. Bamias, A. Vidrich, M. Marini, T.T. Pizarro, 
M.J. McDuffi     e, C.A. Moskaluk, S.M. Cohn, and F. Cominelli. 
2003. Emergence of perianal fi  stulizing disease in the SAMP1/YitFc 
mouse, a spontaneous model of chronic ileitis. Gastroenterology. 124:
972–982.
36. Kosiewicz, M.M., C.C. Nast, A. Krishnan, J. Rivera-Nieves, C.A. 
Moskaluk, S. Matsumoto, K. Kozaiwa, and F. Cominelli. 2001. Th1-
type responses mediate spontaneous ileitis in a novel murine model of 
Crohn’s disease. J. Clin. Invest. 107:695–702.
37. Takedatsu, H., K. Mitsuyama, S. Matsumoto, K. Handa, A. Suzuki, 
H. Takedatsu, H. Funabashi, Y. Okabe, T. Hara, A. Toyonaga, and 
M. Sata. 2004. Interleukin-5 participates in the pathogenesis of ileitis in 
SAMP1/Yit mice. Eur. J. Immunol. 34:1561–1569.
38.  Olson, T.S., G. Bamias, M. Naganuma, J. Rivera-Nieves, T.L. Burcin, 
W. Ross, M.A. Morris, T.T. Pizarro, P.B. Ernst, F. Cominelli, and K. 
Ley. 2004. Expanded B cell population blocks regulatory T cells and 
exacerbates ileitis in a murine model of Crohn disease. J. Clin. Invest. 
114:389–398.
39.  Marini, M., G. Bamias, J. Rivera-Nieves, C.A. Moskaluk, S.B. Hoang, 
W.G. Ross, T.T. Pizarro, and F. Cominelli. 2003. TNF-alpha neutral-
ization ameliorates the severity of murine Crohn’s-like ileitis by abro-
gation of intestinal epithelial cell apoptosis. Proc. Natl. Acad. Sci. USA. 
100:8366–8371.
40. Bamias, G., M. Marini, C.A. Moskaluk, M. Odashima, W.G. Ross, J. 
Rivera-Nieves, and F. Cominelli. 2002. Down-regulation of intestinal 
lymphocyte activation and Th1 cytokine production by antibiotic ther-
apy in a murine model of Crohn’s disease. J. Immunol. 169:5308–5314.
41. Kozaiwa, K., K. Sugawara, M.F. Smith Jr., V. Carl, V. Yamschikov, 
B. Belyea, S.B. McEwen, C.A. Moskaluk, T.T. Pizarro, F. Cominelli, 
and M. McDuffi   e. 2003. Identifi  cation of a quantitative trait locus for 
ileitis in a spontaneous mouse model of Crohn’s disease: SAMP1/YitFc. 
Gastroenterology. 125:477–490.
42. Sugawara, K., T.S. Olson, C.A. Moskaluk, B.K. Stevens, S. Hoang, 
K. Kozaiwa, F. Cominelli, K.F. Ley, and M. McDuffi   e. 2005. Linkage 
to peroxisome proliferator-activated receptor-gamma in SAMP1/YitFc 
mice and in human Crohn’s disease. Gastroenterology. 128:351–360.
43. Burns, R.C., J. Rivera-Nieves, C.A. Moskaluk, S. Matsumoto, F. 
Cominelli, and K. Ley. 2001. Antibody blockade of ICAM-1 and 
VCAM-1 ameliorates infl  ammation in the SAMP-1/Yit adoptive trans-
fer model of Crohn’s disease in mice. Gastroenterology. 121:1428–1436.
44.  El Asmar, R., P. Panigrahi, P. Bamford, I. Berti, T. Not, G.V. Coppa, 
C. Catassi, and A. Fasano. 2002. Host-dependent zonulin secretion 
causes the impairment of the small intestine barrier function after bacte-
rial exposure. Gastroenterology. 123:1607–1615.
45. Meddings, J.B., and I. Gibbons. 1998. Discrimination of site-specifi  c 
alterations in gastrointestinal permeability in the rat. Gastroenterology. 
114:83–92.
46.  Korngold, B., and J. Sprent. 1978. Lethal graft-versus-host disease after 
bone marrow transplantation across minor histocompatibility barriers in 
mice. Prevention by removing mature T cells from marrow. J. Exp. 
Med. 148:1687–1698.
47.  Neutra, M.R., N.J. Mantis, and J.P. Kraehenbuhl. 2001. Collaboration 
of epithelial cells with organized mucosal lymphoid tissues. Nat. 
Immunol. 2:1004–1009.
48. Bruewer, M., A. Luegering, T. Kucharzik, C.A. Parkos, J.L. Madara, 
A.M. Hopkins, and A. Nusrat. 2003. Proinfl  ammatory cytokines dis-
rupt epithelial barrier function by apoptosis-independent mechanisms. 
J. Immunol. 171:6164–6172.
49. Madsen, K.L., D. Malfair, D. Gray, J.S. Doyle, L.D. Jewell, and R.N. 
Fedorak. 1999. Interleukin-10 gene-defi  cient mice develop a primary 
intestinal permeability defect in response to enteric microfl  ora. Infl  amm. 
Bowel Dis. 5:262–270.
50.  Dvorak, A.M., and G.R. Dickersin. 1980. Crohn’s disease: transmission 
electron microscopic studies. I. Barrier function. Possible changes re-
lated to alterations of cell coat, mucous coat, epithelial cells, and Paneth 
cells. Hum. Pathol. 11:561–571.
51. Scott, K.G., J.B. Meddings, D.R. Kirk, S.P. Lees-Miller, and A.G. 
Buret. 2002. Intestinal infection with Giardia spp. reduces epithe-
lial barrier function in a myosin light chain kinase-dependent fashion. 
Gastroenterology. 123:1179–1190.
52.  Kucharzik, T., S.V. Walsh, J. Chen, C.A. Parkos, and A. Nusrat. 2001. 
Neutrophil transmigration in infl  ammatory bowel disease is associated 
with diff  erential expression of epithelial intercellular junction proteins. 
Am. J. Pathol. 159:2001–2009.
53.  Bradley, P.P., D.A. Priebat, R.D. Christensen, and G. Rothstein. 1982. 
Measurement of cutaneous infl  ammation: estimation of neutrophil con-
tent with an enzyme marker. J. Invest. Dermatol. 78:206–209.
54.  Boughton-Smith, N.K.,J.L. Wallace, and B.J. Whittle. 1988. Relationship 
between arachidonic acid metabolism, myeloperoxidase activity and 
leukocyte infi  ltration in a rat model of infl  ammatory bowel disease. 
Agents Actions. 25:115–123.